According to a recent Wall Street Journal report, companies are now hiring storytellers with the same decisiveness reserved ...
Novo Nordisk faces GLP-1 headwinds after the FDA-approved Wegovy pill, and LLY gains share, margins erode, and the pipeline ...
Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback